(Q35540855)

8 August 2017

1 reference

title

A novel mechanism for pulmonary arterial hypertension? (English)

1 reference

8 August 2017

A Novel Mechanism for Pulmonary Arterial Hypertension? (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Cardiology and cardiovascular medicine

13 March 2024

main subject

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

13 March 2024

1

John P. Cooke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14504250

13 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

23 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14504250

13 March 2024

1 reference

8 August 2017

volume

108

1 reference

8 August 2017

issue

12

1 reference

8 August 2017

page(s)

1420-1421

1 reference

Pulmonary arterial hypertension in congenital heart disease

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study

13 March 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

13 March 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension

13 March 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

13 March 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension

13 March 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension

13 March 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension

13 March 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

13 March 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

13 March 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Regulation of nitric oxide production by arginine metabolic enzymes

13 March 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Arginine deficiency accompanies persistent pulmonary hypertension of the newborn

13 March 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

13 March 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Effect of <i>L</i>-Arginine Infusion on Infants with Persistent Pulmonary Hypertension of the Newborn

13 March 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension

13 March 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia

13 March 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension

13 March 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension

13 March 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Primary pulmonary hypertension

13 March 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

13 March 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice

13 March 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000087153.11050.AB

13 March 2024

Identifiers

1 reference

8 August 2017

1 reference